Philips stock soared nearly 30% on Monday to over $27 after the the Dutch medical device maker announced it has agreed to pay ...
The FDA said today that a Philips recall of Trilogy Evo continuous ventilators is Class I, its most serious level of recall.
The U.S. Food and Drug Administration (FDA) has ordered a software recall for a type of ventilator, for fear of "serious injuries or death." The ventilators—the Philips Respironics, Inc. Trilogy EVO, ...
Philips shares surged 35% early on Monday as the medical devices maker announced a smaller-than-expected settlement to ...
The proposed settlement will effectively end more than 700 lawsuits filed after the 2021 recall of millions of the company’s ...
Philips Respironics announced that it agreed to pay over a billion dollars to settle claims stemming from the 2021 U.S.
The settlement comes after a yearslong legal battle concerning 15 million recalled DreamStation CPAP and other respiration ...
The recall, which was initiated by the company in March, pertains to a software issue that can cause a possible power ...
Medical device maker Philips announced a nearly $1.1 billion personal injury settlement over some of its CPAP, ventilators ...
Medical device company Philips reached a settlement Monday to shell out $1.1 billion to cover hundreds of personal injury lawsuits linked to its respiration and sleep apnea machines. The ...